Lopinavir-ritonavir versus darunavir-norvir for hospitalized COVID-19 patients

Conclusion: LPV/r, but not DRV/n demonstrated survival benefits in patients hospitalized for COVID-19 in this observational study.

Source: European Respiratory Journal - October 27, 2023 Category: Respiratory Medicine Authors: Paroczai, D., Bikov, A., Blidaru, A., Bobu, E., Cerbu, B., Marincu, I., Mihaicuta, S., Frent, S. Tags: Respiratory infections and bronchiectasis Source Type: research